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studied (France = 1.8%, 0.85 million; Germany = 3.8%, 2.55
million; Italy = 1.9%, 0.90 million; Spain = 1.2%, 0.41 million;
UK = 3.3%, 1.53 million). Unadjusted results showed signiﬁ-
cant negative associations between metabolic syndrome and
health care resource utilization. After adjusting for covariates
these negative associations remained signiﬁcant (p < 0.001 for
all) Speciﬁcally, adults with metabolic syndrome had 0.2 more
ER visits, 1.2 more days hospitalized, and 4.3 more visits to
medical providers than adults without metabolic syndrome.
CONCLUSION: Metabolic syndrome is a complex condition,
potentially affected my multiple factors. It has substantial eco-
nomic costs in terms of resource utilization.
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OBJECTIVE: Complementary and alternative medicine (CAM)
represents an important group of medical treatments that are
frequently excluded from health economic assessments. Chronic
non-cancer pain is one area where CAM may provide signiﬁcant
patient beneﬁt. The purpose of this study was to describe CAM
use in outpatients with non-cancer chronic pain and to describe
variables of interest in CAM users. METHODS: Prospective
observational analysis at a tertiary care university teaching hos-
pital conducted among outpatients with non-cancer chronic
pain. We collected data using a daily log completed by patients
during a one-week period. Variables included gender, ethnicity,
pain source, type(s) of CAM used, health care utilization, and
work hours missed. RESULTS: Of the 263 patients (75% female,
25% male), 95% used CAM (mean age 50.6, standard deviation
13.8). CAM was used by 94% of Caucasians, 97% of African-
Americans, and 95% other (mean number of CAM 5). Fre-
quently used CAMs included rest (77%), changing position
(66%), hot/cold packs (58%), prayer (41%), exercise (39%),
massage (36%), epidurals (26%), and talking to someone (25%).
Mean number of CAM used by pain source was cancer (3),
headache (4.1), >1 pain source (5.3), musculoskeletal (5.2), rheu-
matology (5.3), and sickle cell (5.7). Patients used 1–3 (low), 4–6
(medium), or >/=7 (high) therapies 32%, 38%, and 30% of the
time, respectively. The mean number of doctor’s appointments
(p = 0.04) and work hours missed (p = 0.03) signiﬁcantly
increased with increasing CAM use (low, medium, or high).
CONCLUSION: CAM utilization is common among patients
with chronic non-cancer pain and should be considered in health
economic assessments. Most patients used one CAM and many
used more than one. Patients using more CAMs had higher
health care utilization and missed more work. Future research
aimed at measuring the incremental cost-effectiveness of CAM in
relation to and in addition to pharmaceutical treatments would
be worthwhile.
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OBJECTIVE: This study aimed to determine the total costs of
back pain and spinal disorders (ICD10: M50–M54) to German
society in 2005 as well as to identify different patterns of health
service utilization of a patient sub-population with recurrent
back pain. In addition, potential cost savings by implementing
guidelines were estimated. METHODS: The costs of low back
pain were assessed by measuring both direct costs of providing
health care to patients, and indirect costs as the value of pro-
ductivity losses. Furthermore a decision tree was constructed to
demonstrate different ways of managing recurrent low back
pain. Data was obtained from two German health insurance
funds for all identiﬁed back pain patients in 2005. The estima-
tion of potential cost savings was based on assumptions of the
Bertelsmann foundation expert-panel. RESULTS: In Germany,
total cost of low back pain reached €6.3 billion in 2005. The
indirect costs due to productivity losses accounted for 39% of
the total costs. Total annual direct costs amounted €3.8 billion,
with an average direct cost of €230 per patient. Nearly 42% of
the direct costs were induced by outpatient treatment, 24% by
physical treatment, 18% by pharmaceuticals and 14% by hos-
pitalisation. Patients with chronic or recurrent back pain (21%
of the study’s population) were accountable for 43% of the
direct costs. By modelling scenarios of best practice medical
care, potential cost savings add up to 24% of the direct costs of
the patient sub-population with recurrent back pain. CON-
CLUSION: Overall, the study conﬁrms the high economic
burden of back pain for the German society. Best practice
medical care was associated with substantial cost saving oppor-
tunities. Further research is needed to establish the cost-
effectiveness of treatment based on guidelines in a prospective
study design.
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OBJECTIVE: To examine whether predisposing, enabling and
need variables in the behavioral model of health services use,
described by Andersen et al., are associated with lower HRQoL
as measured by SF-12 in adults with hemophilia A. METHODS:
Data were from HUGS-V, a prospective multi-center study exam-
ining hemophilia costs and impact of disease among patients at
six U.S. Hemophilia Treatment Centers. Adults with hemophilia
completed questionnaires and variables were selected according
to the Andersen’s model, including socio-demographics, self-
reported co-morbidities, joint pain and motion limitation. A
linear regression model was used to assess factors associated with
SF-12 Physical Component Summary (PCS) and Mental Compo-
nent Summary (MCS) scores. RESULTS: Complete data from
152 patients were analyzed. Mean age was 33.7 years (range
18–65). Sixty-four percent had severe hemophilia. 82% reported
one to seven co-morbidities. Thirty-eight percent reported severe
joint pain and 57% reported severe motion limitation in at least
one joint. Mean PCS was 43.2  10.8 and mean MCS was
50.9  10.1. Adults with severe hemophilia had lower PCS
scores compared to those with mild or moderate hemophilia
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